# LEADMED

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/leadmed

- Industry: Healthcare
- Headquarters: Shenzhen, China
- Website: www.leadmed.cn
- Total disclosed funding: $4.2M
- Latest round: Series A (Sep 20, 2019)
- Investors on record: 1

## About

LeadMed is a developer of advanced medical devices and diagnostic tools aimed at enhancing patient care and outcomes in healthcare environments through innovative technology.Founded in 2013 and headquartered in Shenzhen, China, LeadMed focuses on the design and distribution of medical devices and diagnostic solutions. In September 2019, the company secured RMB 30 million in Series A funding from Magsun Capital, which represents the total amount raised by the firm. There is no information regarding company pivots, subsidiaries, or founders available.LeadMed specializes in the development and distribution of advanced medical devices and diagnostic tools aimed at improving patient outcomes in healthcare settings. Their core product offerings include innovative imaging systems and diagnostic kits designed to facilitate early disease detection and enhance treatment precision. These products are utilized by hospitals, clinics, and diagnostic laboratories, effectively addressing critical needs in various therapeutic areas, including oncology and cardiology. The company markets its products primarily in North America and Europe, focusing on enhancing the efficiency of healthcare delivery through superior technology. LeadMed's solutions cater to a diverse clientele, including healthcare professionals and institutions seeking reliable and state-of-the-art medical equipment.LeadMed generates revenue through direct sales of its products to healthcare institutions and professionals, as well as through strategic partnerships with distributors in targeted geographical markets. The company engages in B2B transactions, offering a range of diagnostic and imaging solutions that healthcare providers utilize to deliver high-quality patient care. Pricing structures for their flagship products are determined based on the complexity and innovation of the technology, with distinct pricing tiers designed to accommodate varying client needs. These products are integral to the operational efficiency of healthcare providers, thus ensuring a consistent demand for LeadMed's offerings within the medical sector. The company’s revenue model emphasizes long-term relationships with clients, promoting loyalty and recurrent business through effective service and product support.LeadMed plans to utilize the recent funding raised in September 2019 to support the development of new diagnostic tools and imaging systems. The company aims to expand its market presence into additional regions in Europe and North America by the end of 2023, enhancing accessibility to its innovative medical solutions. The upcoming products are expected to further strengthen LeadMed's position in the healthcare sector and address unmet needs in patient care.

## Funding rounds

- Series A, Sep 20, 2019, $4.2M — Magsun Capital

## Investors

- Magsun Capital (https://capitalatlas.ai/funds/magsun-capital) — Series A